Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Approved dosing regimen reduces the burden for eligible patients, their families, and the broader healthcare system by extending infusion interval from every-two-weeks to every-four-weeks for those st ...

Emerging research links the gut microbiome to heart health. Beneficial bacteria may protect the heart, while others increase ...

Abstract: The integration of Artificial Intelligence (AI) in education has shown promising potential to enhance learning experiences and provide personalized assistance to students. However, existing ...